Dr. Richardson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-7510
Education & Training
- Brigham and Women's HospitalFellowship, Cytopathology, 2020 - 2021
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2017 - 2020
- Case Western Reserve University School of MedicineClass of 2017
- Stanford UniversityBS, Chemistry, 2003 - 2007
Certifications & Licensure
- MA State Medical License 2017 - 2026
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 42 citationsA Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer.Romualdo Barroso-Sousa, Ian E. Krop, Lorenzo Trippa, Zhenying Tan-Wasielewski, Tianyu Li
Clinical Breast Cancer. 2020-01-30 - 115 citationsQuiescent cancer cells resist T cell attack by forming an immunosuppressive niche.Pilar Baldominos, Alex Barbera-Mourelle, Olga Barreiro, Yu Huang, Andrew Wight
Cell. 2022-05-12 - 89 citationsEffect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A R...Sara M. Tolaney, Romualdo Barroso-Sousa, Tanya Keenan, Tianyu Li, Lorenzo Trippa
JAMA Oncology. 2020-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: